QOL effect of treatment duration with vitamin K antagonists

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.430, 2003-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vitamin K antagonists associated with arterial calcinosis

Reactions Weekly, Vol. 1, Iss. 1258, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3816-3826

Bentham Science Publishers

Access to resources Recommend Favorite

Haemorrhagic Complications of Vitamin K Antagonists in the Elderly: Risk Factors and Management

By Pautas Eric

Drugs & Aging, Vol. 23, Iss. 1, 2006-01 ,pp. : 13-25

Adis International

Access to resources Recommend Favorite

Vitamin K antagonists linked to coronary calcification in AF patients

Reactions Weekly, Vol. 1, Iss. 1364, 2011-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Comparative Pharmacokinetics of Vitamin K Antagonists: Warfarin, Phenprocoumon and Acenocoumarol

By Ufer Mike

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1227-1246

Adis International

Access to resources Recommend Favorite